Amphastar Pharmaceuticals (AMPH) Net Equity Issued and Repurchased (2015)
Amphastar Pharmaceuticals' (AMPH) quarterly Net Equity Issued and Repurchased came in at $9.8 million in Q2 2015, up 978.35% quarter-over-quarter from $910000.0 in Q1 2015.
Amphastar Pharmaceuticals (AMPH) Net Equity Issued and Repurchased (2015) Analysis & Trends
Amphastar Pharmaceuticals' Net Equity Issued and Repurchased history runs 1 years deep, the most recent figure standing at $9.8 million for Q2 2015.
- On a quarterly basis, Net Equity Issued and Repurchased changed N/A year-over-year to $9.8 million in Q2 2015; TTM through Jun 2015 was $10.7 million, a N/A change from a year earlier, with the FY2014 full-year figure at $38.0 million, changed N/A from the prior year.
- Net Equity Issued and Repurchased advanced to $9.8 million in Q2 2015 per AMPH's latest filing, from $910000.0 in the prior quarter.
- Across five years, Net Equity Issued and Repurchased topped out at $9.8 million in Q2 2015 and bottomed at $910000.0 in Q1 2015.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Equity Issued and Repurchased (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | - |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | - |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | - |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | - |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 500,000.00 |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 23.60 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | - |
| 10 | Amphastar Pharmaceuticals | 855.23 Mn | 684.09 Mn | 70.32 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2015 | 9.81 Mn |
| Jun 30, 2015 | 9.81 Mn |
| Mar 31, 2015 | 910,000.00 |
| Mar 31, 2015 | 910,000.00 |